DIFFERENTIAL BEHAVIORAL INTERACTIONS BETWEEN THE DOPAMINE-D-1 ANTAGONIST SCH-23390 AND THE DOPAMINE-D-2 ANTAGONISTS METOCLOPRAMIDE AND SULPIRIDE IN NONHABITUATED MICE

被引:13
作者
CHANDLER, CJ
STARR, BS
STARR, MS
机构
[1] UNIV LONDON,DEPT PHARMACOL,LONDON WC1N 1AX,ENGLAND
[2] HATFIELD POLYTECH,SCH HLTH & HUMAN SCI,PSYCHOL GRP,HATFIELD AL10 9AB,HERTS,ENGLAND
关键词
D-1; receptors; D-2; Dopamine; Metoclopramide; Mice; Motor behaviour; SCH; 23390; Sulpiride;
D O I
10.1016/0091-3057(90)90157-D
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This study investigated the effects of the selective D-1 antagonist SCH 23390, when administered alone and in combination with a typical (metoclopramide) or atypical neuroleptic (sulpiride), on species-typical behaviours in nonhabituated mice. When tested singly, all three compounds caused a progressive dose-dependent inhibition of locomotion, rearing and grooming, though their potencies varied widely. Mixtures of a threshold dose of 0.01 mg/kg SCH 23390 and metoclopramide (0.05-1.25 mg/kg) interacted synergistically to promote hypomotility and to decrease rearing, but did not affect grooming. By contrast, combinations of 0.01 mg/kg SCH 23390 and sulpiride (2-10 mg/kg) resulted in a marked potentiation of grooming, but only additive reductions in horizontal and vertical movements, consistent with sulpiride and metoclopramide occluding different populations of D-2 receptors. The results show that blockade of D-1 receptors and certain populations of D-2 receptors can interact positively to modify animal motor behaviour, and add a fresh perspective to the concept that these two types of dopamine receptor normally work interdependently to control movements of the body. © 1990.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 23 条
[1]  
ALTAR CA, 1988, N-S ARCH PHARMACOL, V338, P162
[2]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[3]   REVIEW - D1 DOPAMINE RECEPTOR - THE SEARCH FOR A FUNCTION - A CRITICAL-EVALUATION OF THE D1/D2 DOPAMINE RECEPTOR CLASSIFICATION AND ITS FUNCTIONAL IMPLICATIONS [J].
CLARK, D ;
WHITE, FJ .
SYNAPSE, 1987, 1 (04) :347-388
[4]   DIFFERENTIAL ACTIVITIES OF SOME BENZAMIDE DERIVATIVES ON PERIPHERAL AND INTRA-CEREBRAL ADMINISTRATION [J].
COSTALL, B ;
FORTUNE, DH ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (12) :796-798
[5]  
DAWSON TM, 1987, J NEUROSCI, V8, P2352
[6]   EVIDENCE THAT STRIATAL EFFERENTS RELATE TO DIFFERENT DOPAMINE-RECEPTORS [J].
HERRERAMARSCHITZ, M ;
UNGERSTEDT, U .
BRAIN RESEARCH, 1984, 323 (02) :269-278
[7]  
HU XT, 1988, J NEUROSCI, V8, P4340
[8]   SCH-23390 - THE 1ST SELECTIVE DOPAMINE D-1 ANTAGONIST [J].
HYTTEL, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) :153-154
[9]   D-1 AND D-2 RECEPTOR BLOCKADE HAVE ADDITIVE CATALEPTIC EFFECTS IN MICE, BUT RECEPTOR EFFECTS MAY INTERACT IN OPPOSITE WAYS [J].
KLEMM, WR ;
BLOCK, H .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) :223-229
[10]   SYSTEMATIC STUDY OF THE PHARMACOLOGICAL ACTIVITIES OF DOPAMINE ANTAGONISTS [J].
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
LIFE SCIENCES, 1979, 24 (24) :2201-2216